Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1

Toxicology in Vitro

Volumn 16, Issue 4, 2002, Pages 339-347

  Bassi, A M ^a   Ledda, S ^b   Valentini, S ^b   De Pascale, M C ^a   Rossi, S ^b   Odetti, P ^b   Cottalasso, D ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Age; Glycoxidation; In vitro cytotoxicity; Oxidative stress; Pentosidine; TBARs

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LACTATE DEHYDROGENASE; NEUTRAL RED; PENTOSIDINE; RIBOSE; TETRAZOLIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ARGININE; DRUG DERIVATIVE; LYSINE;

ANIMAL CELL; CELL DAMAGE; CELL LINE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DIABETES MELLITUS; LIPID PEROXIDATION; MACROPHAGE; MOUSE; NONHUMAN; TOXICITY TESTING; UREMIA; ANIMAL; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMAL; ARGININE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; LIPID PEROXIDATION; LYSINE; MACROPHAGES; MICE; OXIDATIVE STRESS; RIBOSE; SUPPORT, NON-U.S. GOV'T; ANIMALS;

BOVINAE; MURINAE;

EID: 0036314675     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(02)00016-4     Document Type: Conference Paper

References (48)

1. Changes of CYP 1A1, GST and ALDH 3 enzymes in hepatoma cell lines undergoing enhanced lipid peroxidation
2. Decreased serum beta-D-mannosidase activity in diabetic patients, in comparison with other glycosidases
3. Toxicity determined in vitro by morphological alterations and neutral red absorbtion
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Advanced glycation: Chemistry, biology and implications for diabetes and aging
6. Early glycation products produce pentosidine cross links on native proteins. Novel mechanism of pentosidine formation and propagation of glycation
7. Advanced glycation end-products in children and adolescents with diabetes mellitus: Relation to glycaemic control and early microvascular complications
8. Autofluorescent structures in cultured WI-38 cells
9. Glycation, glycoxidation, and cross-linking of collagen by glucose. kinetics, mechanisms, and inhibition of late stages of the Maillard reaction
10. Glycated proteins in diabetes
11. Impaired protein degradation may account for the accumulation of abnormal proteins in aging cells
12. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy
13. Effect of kidney or kidney-pancreas transplantation on plasma pentosidine
14. Lipid peroxidation and disintegration of the cell membrane structure in cultures of rat lung fibroblasts treated with asbestos
15. Isolation of autofluorescent aged human fibroblasts by flow sorting
16. The relationship of oxidative dna damage marker 8-hydroxydeoxyguanosine and glycoxidative damage marker pentosidine
17. Activation of the receptor for AGE triggers a p21 ras dependent mitogen activated protein kinase pathway regulated by oxidant stress
18. Role of glycation in aging
19. Cytotoxicity of advanced glycation end-products is mediated by oxidative stress
20. Oxidative stress in hemodialysis
21. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis
22. Increased glycoxidation and lipoperoxidation in the collagen of the myocardium in hemodialysis patients
23. Immunohistochemical detection of A. G. E.s in diabetic tissues monoclonal antibodies to pyrraline
24. Beta-2-microglobulin modified with AGEs is a major component of hemodialysis-associated amyloidosis
25. Identification of pentosidine as a native structure for advanced glycated end-products in beta-2-micro-globulin-containing amyloid fibrils in patients with dialysis-related amyloidosis
26. Accumulation of albumin-linked and free-form pentosidine in the circulation of uraemic patients with end-stage renal failure: Renal implications in the pathology of pentosidine
27. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
28. Serum levels of 3-deoxyglucosone and tissue contents of advanced glycation end-products are increased in streptozotocin-induced diabetic rats with nephropathy
29. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects
30. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines
31. In vitro and in vivo alterations of enzymatic glycosylation in diabetes
32. Lipoxidation products as biomarker of oxidative damage to protein during lipid peroxidation reactions
33. An evaluation of three in vitro cytotoxicity assays
34. Increased accumulation of glycoxidation product carboxy-methyllysine in human tissues in diabetes and aging
35. RAGE: A novel receptor for AGEs
36. Cellular receptors for AGEs: Implication for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
37. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM
38. Cell-associated pentosidine as a marker of aging in human diploid cells in vitro in vivo
39. Serum glycosidases in diabetes mellitus in relation to the retinopathy and to the length of the disease
40. Cellular senescence revisited: A review
41. Atherogenesis and advanced glycation: Promotion, progression and prevention
42. Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of A. G. E
43. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules
44. Fructose mediated crosslinking of proteins
45. Decreased sialidase activity in mononuclear leucocytes of type 1 diabetic subjects: Relationship to diabetic complications and glycaemic control
46. Lactic dehydrogenase activity in blood
47. Enhanced cellular oxidant stress by the interaction of AGEs with their receptors/binding proteins
48. Nonenzymatically glycated to tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide